Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Leading Scientists Warn Over Lack Of Dementia Investment
The UK needs a national plan for dementia research or the country will pay the price, the UK"s top scientists are warning today.
generic viagra online
Federal Family Planning Program: New Report
A REVIEW OF THE HHS FAMILY PLANNING PROGRAM: MISSION, MANAGEMENT, AND MEASUREMENT OF RESULTS, new from the Institute of Medicine, recommends that family planning be re-established as a core value in public health practice. The report urges the Department of Health and Human Services and Congress to support the Title X program as the leading voice for the nation"s family planning effort.
News of the day
Amgen Grant To Study Treatments For Older Leukemia Patients Received By Loyola Fellow
Dr. Aileen Go of Loyola University Health System, who is studying treatment options for older leukemia and lymphoma patients, has won a prestigious Amgen Foundation Fellowship grant.
Oncology

What Is The Relationship Between Hepatocellular Carcinoma And Type 2 Diabetes Mellitus?

Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide and the third leading cause of cancer-related deaths. Type 2 diabetes mellitus has been associated with HCC. However, the relationship between type 2 diabetes mellitus and the underlying liver cirrhosis, and the effects of antidiabetic therapy on HCC risk have not yet been fully evaluated. A research team led by Dr. Valter Donadon from Pordenone Hospital addressed this question. Their study was published in the World Journal of Gastroenterology. Enrolled in this study were 465 HCC patients, 618 cirrhosis patients and 490 control subjects. They evaluated the odds ratio (OR) for HCC by univariate and multivariate analysis. Moreover, OR for HCC in diabetic subjects treated with insulin or sulphanylureas and with metformin were calculated. The prevalence of diabetes mellitus was 31.2% in HCC, 23.3% in cirrhotic patients and 12.7% in the Control group. By univariate and multivariate analysis, the OR for HCC in diabetic patients were respectively 3.12 (95%CI: 2.2-4.4, P World J Gastroenterol 2009; 15(20): 2506-2511 Correspondence to: Dr. Valter Donadon, Department of Medicine, Internal Medicine 3rd, Pordenone Hospital, Via Montereale 24, Pordenone 33170, Italy. Lai-Fu Li World Journal of Gastroenterology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009